PubMed Health⌕ Search

Biomedical subjects

M K Brenner

Publications and source records attributed to M K Brenner.

204 records · Page 12Linked to original sources

The interaction of specific T-cell help and non-specific B-cell growth factors in the production of anti-tetanus antibody by human B cells grown in serum-free microcultures.

Apart from a brief period after in-vivo immunization, only a minority of human donors provide peripheral lymphocytes that synthesize specific antibody on stimulation with tetanus toxoid in vitro. A 20 microliters hanging drop microculture technique using serum-free medium has been adapted to analyse the conditions under which B cells mature into antibody-secreting cells. Multiple permutations of antigen dose, cell concentration and T:B cell ratios have been examined. The results indicate that in-vitro failure of antigen response by the majority of donors is not due simply to an inappropriate choice of culture conditions. The addition to antigen-stimulated cultures of a lectin-free conditioned medium derived from pokeweed mitogen-stimulated peripheral lymphocytes, enables B cells from the majority of donors to produce high titres of specific antibody, in a T-dependent manner, for up to 24 months after immunization. The observed failure of prolonged antigen responsiveness in vitro thus appears to represent a failure to expand a population of antigen-specific B cells, rather than indicating an absence of such clones.

Antibodies, Bacterial↗

Human anti-tetanus antibody response in vitro: autologous and allogeneic T cells provide help by different routes.

Human B cells will make anti-tetanus antibody in vitro in the presence of antigen and T cells. These T cells may be autologous, but allogeneic T lymphocytes function equally well provided they are first irradiated. The allogeneic cells provide help by a different route. Co-culture of allogeneic cells produces a degree of polyclonal activation of B cells and a much higher level of IgM anti-tetanus antibody than autologous cultures. Depletion of tetanus toxoid or alloantigen-reactive T cells by 3H-thymidine suicide indicates that in autologous cultures help for anti-tetanus toxoid antibody production is provided by antigen-reactive T cells while in allogeneic cultures antibody production is dependent on the presence of alloreactive T cells. The implications for assessing human T and B cell function are discussed.

Antibodies, Bacterial↗

Emerging applications of gene transfer in the hematopoietic cancers.

PURPOSE: Originally conceived as a means to replace or correct defective genes in patients with inherited disorders, gene transfer has shown broad potential for medical intervention in the hematopoietic cancers and for study of hematopoietic stem cell biology. The purpose of this article is to review emerging applications of gene therapy with special reference to hematopoietic neoplasia. RESULTS: Gene transfer strategies now under investigation in the hematopoietic cancers focus on (a) repair of one or more genetic defects associated with the malignant process, (b) delivery of a prodrug-metabolizing enzyme that causes tumor cells to become sensitive to the corresponding anticancer drug, (c) modification of immune responses to the cancer, or (d) introduction of drug resistance genes to increase the therapeutic index of cytotoxic agents. Finally, by marking normal or malignant cells with readily detectable genes, one can monitor the efficacy of therapy or study the dynamics of stem cell behavior in vivo. CONCLUSION: Despite their undisputed contributions to our knowledge of the hematopoietic cancers, gene transfer studies have been limited by the quality of vector technologies. As transduction efficiencies and gene regulatory mechanisms improve, gene transfer can be expected to evolve into a major therapeutic modality in its own right.

Gene Transfer Techniques↗